Dan Shu

Chongqing Key Laboratory Of Molecular Oncology And Epigenetics
Chongqing, 400016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer.

ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 29, 2025

SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer.

SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer.

Journal: Cell death & disease

Published: January 24, 2024

Association of depressive symptoms and sleep disturbances with survival among US adult cancer survivors.

Association of depressive symptoms and sleep disturbances with survival among US adult cancer survivors.

Journal: BMC medicine

Published: January 02, 2024

UTRN as a potential biomarker in breast cancer: a comprehensive bioinformatics and in vitro study.

UTRN as a potential biomarker in breast cancer: a comprehensive bioinformatics and in vitro study.

Journal: Scientific reports

Published: December 28, 2023

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy.

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy.

Journal: Annals of medicine

Published: October 04, 2022

MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer.

MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer.

Journal: Life (Basel, Switzerland)

Published: August 11, 2022

Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients.

Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients.

Journal: Journal of oncology

Published: August 07, 2022

Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer.

Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer.

Journal: Journal of immunology research

Published: April 03, 2022

A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma.

A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma.

Journal: Aging

Published: October 05, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026